Dystrophin constructs and methods of use thereof

CA3328987A1Undetermined Publication Date: 2025-10-30CANBRIDGE PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CA3328987
Authority / Receiving Office
CA · CA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-04-25
Filing Date
2025-04-25
Publication Date
2025-10-30
Patent Text Reader

Abstract

The present disclosure provides gene constructs that encode a truncated dystrophin protein. The present disclosure also provides systems and methods for delivering a truncated dystrophin protein in a subject, and methods for treating a subject having a dystrophin-associated disease or disorder, e.g., muscular dystrophy, e.g., Duchenne muscular dystrophy (DMD).
Need to check novelty before this filing date? Find Prior Art